Stockreport

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems [Canadian Business Journal (Canada)]

XORTX Therapeutics Inc.  (XRTX) 
PDF CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“Companynovel new chemical entity, VB4-P5pre-IND (Investigational New Drug)Dr. Allen Davidoff [Read more]